In our integrative pan-cancer analysis, the results showed that overexpression of YAP1 only predicted poor prognosis in PAAD and LGG, which was inconsistent with the reported that YAP overexpression predicted worse OS in LIHC, ESCA, BLCA, and BRCA (Wu et al., 2019). This evidence concerns the gene YAP1 and cancer.